Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
This paper reviews the cumulative access limits (CALs) under the Rapid Credit Facility (RCF) of the PRGT. As part of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback